InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-25.0%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Woiwode Thomas, Director. Insider active across 4 companies, notably Aligos Therapeutics, Inc.. Cumulatively, 4 filings have been logged. Split: 1 buy · 0 sell. Total volume traded: €4.8m. Activity tracked since 11 June 2021. The latest transaction was disclosed on 29 April 2022 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Woiwode Thomas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
2,118,644 shares@ US$2.36100.0% of flowCommon StockSEC:0000899243-22-016387:0
Canonical exit: 28 Jul 2022 (T+90)
444,744 shares0Common StockSEC:0000899243-21-034443:0
997,940 sharesCommon StockSEC:0001140361-21-022782:0
485,979 shares0Common StockSEC:0000899243-21-023881:0
4 of 4 declarations
About Woiwode Thomas
Thomas Woiwode is a Board Member at Aligos Therapeutics, Inc., Millendo Therapeutics, Inc., and Gritstone bio, Inc. He brings his expertise in governance and strategy, contributing to the direction of these companies in the biopharmaceutical sector.
